COVID-19 death due to High blood sugar: Patients with elevated blood sugar levels without a diagnosis of previous diabetes have a higher risk of death and a higher risk of serious complications of infectious disease, a new study has found.
According to scientists, including at Tongji Medical College in China, previous studies have developed high blood sugar because it is associated with a higher risk of death and adverse effects in COVID-19 patients.
Patients with elevated blood sugar levels without a diagnosis of previous diabetes have a higher risk of death from COVID-19 and are at increased risk for serious complications from this infectious disease.
“This study shows, for the first time, that elevated FBG at admission is independently associated with increased 28-day mortality and percentages of in-hospital complications in COVID-19 patients without a previous diagnosis of diabetes,” said scientists.
Previous studies have established that COVID-19 death due to High blood sugar: Patients with elevated blood sugar levels without a diagnosis of previous diabetes have a higher risk of death and a higher risk of serious is associated with an increased risk of death and adverse effects in COVID-19 patients.
However, there is no direct association between high blood glucose (FBG) levels over hospitalization and the effect of COVID-19 patient treatment without a diagnosis of diabetes. Scientists examined the number of patients and clinics, 28-day outcomes, hospital complications, and symptoms of CRB-65 – a four-point risk assessment for asthma, including confusion, respiratory rate, and blood pressure. Depression and age.
A total of 605 COVID-19 patients were included in the study, including 114 hospitalized patients. According to the study, the average age of participants was 59 years and 322 males. A total of 208 people have one or more substandard conditions but have not been diagnosed with diabetes, high blood pressure is the most common form of hypertension.
The study found that another 17 percent were at the risk of developing diabetes and more than half were in the ‘normal’ FBG category. Patients in the FBG group had the highest risk of dying 2.3 times, investigators said. They said men were 75 percent more likely to die than women, and that patients with high CRB 65 levels were also at greater risk of death. This study shows that elevated FBG at admission is associated with an independent of 28% and a percentage of complications in hospitals and patients of COVID-19 without a prior diagnosis of diabetes. They said that critically ill patients could develop severe insulin resistance, which is characterized by high blood sugar and insulin levels.
Patients unrelated to diabetes, such as severe sepsis, systemic immune reaction syndrome (SIRS), and traumatic brain injury, have high blood sugar. The authors suggest that high blood-sugar changes that focus on blood clots, further deterioration of blood vessel wall function, and increased production of immune cells are among the possible mechanisms of this high mortality. Because most patients with COVID-19 are at risk for disruption of glucose metabolism, blood sugar, and blood sugar tests should be recommended for patients with COVID-19 who do not have pre-diabetes.
Do Follow us on Twitter